|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9 Suppl
|
|
pubmed:dateCreated |
1996-12-6
|
|
pubmed:abstractText |
The cardioprotective role of adenosine in various models of ischemia-reperfusion, including adenosine supplementation to cardioplegic formulations, has been studied extensively. The appropriate dose of adenosine in humans is uncertain and could be limited by systemic hypotension or AV block.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
pubmed-author:ChristakisG TGT,
pubmed-author:CohenE AEA,
pubmed-author:DeemarK AKA,
pubmed-author:Feder-ElituvRR,
pubmed-author:FremesS ESE,
pubmed-author:GoldmanB SBS,
pubmed-author:IazettaJJ,
pubmed-author:LevyS LSL,
pubmed-author:MallidiH RHR,
pubmed-author:WalkerS ESE,
pubmed-author:WongB IBI
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
II370-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8901777-Adenosine,
pubmed-meshheading:8901777-Adult,
pubmed-meshheading:8901777-Aged,
pubmed-meshheading:8901777-Female,
pubmed-meshheading:8901777-Heart Arrest, Induced,
pubmed-meshheading:8901777-Humans,
pubmed-meshheading:8901777-Male,
pubmed-meshheading:8901777-Middle Aged,
pubmed-meshheading:8901777-Phenylephrine,
pubmed-meshheading:8901777-Potassium
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Phase 1 human trial of adenosine-potassium cardioplegia.
|
|
pubmed:affiliation |
Department of Pharmacy, University of Toronto, Canada. Stephen.Fremes@sunnybrook.utoronto.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
